FindTrial
Sign In

To Compare the Crystallization Patterns in Blood Samples of Oral Submucous Fibrosis, Oral Cancer and Healthy Individuals

Comparative Evaluation Of Crystallization Patterns In Oral Submucous Fibrosis, Oral Squamous Cell Carcinoma and Healthy Individuals- A Prospective Serological Study - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/02/062193
Enrollment
114
Registered
2024-02-01
Start date
Unknown
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C00-C14- Malignant neoplasms of lip, oral cavity and pharynx Health Condition 2: K135- Oral submucous fibrosis

Interventions

Intervention1: nil: NIL

Sponsors

MGM Dental college and hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Group I- Clinically diagnosed cases of Oral submucous fibrosis Group II- Clinicopathologically diagnosed cases of Oral Squamous Cell Carcinoma Group III- Healthy individuals advised for blood investigations for routine dental surgical procedures without any known medical history

Exclusion criteria

Exclusion criteria: Group I- 1.Patients undergoing treatment for OSMF 2.Patient with history of scleroderma, amyloidosis, generalized fibromatosis. 3. Patients with systemic conditions like heart diseases, diabetes mellitus, thyrotoxicosis, liver diseases, pregnancy, oestrogen therapy, etc. 4.Patients those who are not willing to participate. Group II 1. Recurrent cases of oral squamous cell carcinoma 2. Patients undergoing /undergone treatment of OSCC. 3. Patients with systemic conditions like heart diseases, diabetes mellitus, thyrotoxicosis, liver diseases, pregnancy, oestrogen therapy, etc 4. Patients diagnosed other than OSCC after histopathological examination. 5. Patients those who are not willing to participate. Group III 1. Patients those who are not willing to participate

Design outcomes

Primary

MeasureTime frame
To Evaluate and Compare the Crystallization Patterns in Oral Submucous Fibrosis, Oral Squamous Cell Carcinoma and Healthy IndividualsTimepoint: Blood samples will be collected at the time of patient presentation from Oral Submucous Fibrosis Oral Squamous Cell Carcinoma patients and healthy individuals. The crystallization patterns will be observed 24 hours after the sample collection and crystallization patterns of oral submucous fibrosis and oral squamous cell carcinoma will be compared with the crystallization patterns of healthy individuals—

Secondary

MeasureTime frame
To compare the crystallization patterns in different clinical stages in Oral Submucous Fibrosis Cases.Timepoint: After taking a patients informed consent detailed case history will be taken for study group & blood samples will be collected—

Countries

India

Contacts

Public ContactDR KAMLESH DEKATE

MGM DENTAL COLLEGE AND HOSPITAL NAVI MUMBAI

dr.kamleshdekate@gmail.com9223290372

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026